Participation in the EVA 2019 congress & PTA clinical training, the University of Patras
Rontis participated, with a delegation of foreign physician guests from Iran and Vietnam, in the EVA (EndoVascular Access) 2019 congress, organised in the Conference & Cultural Centre, the University of Patras, on the 21st and the 22nd of June 2019, followed by a live product & clinical training session organised on the 24th and the 25th of June in the Interventional Radiology Suite of the University of Patras.
During the EVA congress, which constitutes the first event of an annual, multidisciplinary, highly scientific meeting with a strategic purpose of training and educating physicians on endovascular procedures performed in Hemodialysis, our guests had the opportunity to attend sessions on dysfunctional access treatment, thrombectomy procedures, central venous catheters, central venous stenosis treatment, no-option patient procedures, immature fistulae treatment, trial updates together with fundamental courses on u/s mapping, and clinical evaluation of dialysis access. Invited speakers included physicians from the U.S.A., Europe, Africa and Asia, while the congress participants included interventional radiologists, nephrologists, vascular surgeons and physicians with an interest in endovascular dialysis access treatment.
Following the EVA congress, our guests joined their Greek colleagues, interventional radiologists of significant experience and international reputation, in treating patients suffering from peripheral vascular disease by employing angioplasty techniques. Thus, the delegation of foreign physicians received product & clinical training using Rontis endovascular devices.
All participants expressed their gratitude for the opportunity to attend the EVA congress and work in real cases, having obtained very useful experiences for their future work. Furthermore, our team received very warm feedback in appreciation of the hospitality offered and the effort made in maximizing the value of both events during our guests’ 6-day visit.
Rontis was represented by Dr Athanassios Vratimos, International Product Manager, Medical Devices Division, Rontis AG, Mr Pavlos Zakakis, Business Development Associate, Medical Devices Division, Rontis AG and Mr Gregory Karagiannis, Product Specialist, Endo-Neurovascular Business Unit, Rontis Hellas S.A.